5FED
EGFR kinase domain in complex with a covalent aminobenzimidazole inhibitor.
Experimental procedure
Experimental method | SINGLE WAVELENGTH |
Source type | SYNCHROTRON |
Source details | ALS BEAMLINE 5.0.3 |
Synchrotron site | ALS |
Beamline | 5.0.3 |
Temperature [K] | 100 |
Detector technology | CCD |
Collection date | 2011-09-09 |
Detector | ADSC QUANTUM 315r |
Wavelength(s) | 0.97648 |
Spacegroup name | I 2 3 |
Unit cell lengths | 145.584, 145.584, 145.584 |
Unit cell angles | 90.00, 90.00, 90.00 |
Refinement procedure
Resolution | 59.434 - 2.651 |
R-factor | 0.1865 |
Rwork | 0.185 |
R-free | 0.21750 |
Structure solution method | MOLECULAR REPLACEMENT |
Starting model (for MR) | 2j6m |
RMSD bond length | 0.009 |
RMSD bond angle | 1.054 |
Data reduction software | HKL-2000 |
Data scaling software | SCALEPACK |
Phasing software | PHASER |
Refinement software | PHENIX ((1.10.1_2155: ???)) |
Data quality characteristics
Overall | Outer shell | |
Low resolution limit [Å] | 80.000 | 2.740 |
High resolution limit [Å] | 2.650 | 2.650 |
Rmerge | 0.083 | 0.683 |
Number of reflections | 15067 | |
<I/σ(I)> | 22.6 | 2.72 |
Completeness [%] | 100.0 | 100 |
Redundancy | 6.2 | 6.3 |
Crystallization Conditions
crystal ID | method | pH | temperature | details |
1 | VAPOR DIFFUSION, SITTING DROP | 7.9 | 293 | 1.35M potassium sodium tartrate, 0.1M HEPES pH 7.9 |